Sunshine Act Meeting Notice, 37237 [2013-14807]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 119 / Thursday, June 20, 2013 / Notices
INTERNATIONAL TRADE
COMMISSION
[USITC SE–13–015]
Sunshine Act Meeting Notice
United
States International Trade Commission.
TIME AND DATE: June 28, 2013 at 11:00
a.m.
PLACE: Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: None.
2. Minutes.
3. Ratification List.
4. Vote in Inv. Nos. 731–TA–1210–1212
(Preliminary) (Welded Stainless
Steel Pressure Pipe from Malaysia,
Thailand, and Vietnam). The
Commission is currently scheduled
to transmit its determinations to the
Secretary of Commerce on or before
July 1, 2013; Commissioners’
opinions are currently scheduled to
be transmitted to the Secretary of
Commerce on or before July 9, 2013.
5. Outstanding action jackets: None.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
AGENCY HOLDING THE MEETING:
Issued: June 18, 2013.
By order of the Commission.
William R. Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2013–14807 Filed 6–18–13; 11:15 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–365]
Proposed Adjustments to the
Aggregate Production Quotas for
Schedule I and II Controlled
Substances and Assessment of
Annual Needs for the List I Chemicals
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine for 2013
Drug Enforcement
Administration (DEA), Department of
Justice.
ACTION: Notice with request for
comments.
TKELLEY on DSK3SPTVN1PROD with NOTICES
AGENCY:
This notice proposes to adjust
the 2013 aggregate production quotas for
several controlled substances in
schedules I and II of the Controlled
SUMMARY:
VerDate Mar<15>2010
17:01 Jun 19, 2013
Jkt 229001
Substances Act (CSA) and assessment of
annual needs for the list I chemicals
ephedrine, pseudoephedrine, and
phenylpropanolamine, as well as to
establish the 2013 aggregate production
quotas for three recently temporarily
scheduled substances.
DATES: Electronic comments must be
submitted and written comments must
be postmarked on or before July 22,
2013. The electronic Federal Docket
Management System will not accept
comments after midnight Eastern Time
on the last day of the comment period.
ADDRESSES: To ensure proper handling
of comments, please reference ‘‘Docket
No. DEA–365’’ on all electronic and
written correspondence. DEA
encourages all comments be submitted
electronically through https://
www.regulations.gov using the
electronic comment form provided on
that site. An electronic copy of this
document is also available at https://
www.regulations.gov for easy reference.
Paper comments that duplicate the
electronic submission are not necessary
and are strongly discouraged as all
comments submitted to
www.regulations.gov will be posted for
public review and are part of the official
docket record. Should you, however,
wish to submit written comments via
regular or express mail, they should be
sent to the Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODL, 8701
Morrissette Drive, Springfield, VA
22152.
FOR FURTHER INFORMATION CONTACT: John
W. Partridge, Executive Assistant, Office
of Diversion Control, Drug Enforcement
Administration, 8701 Morrissette Drive,
Springfield, VA 22152; Telephone: (202)
307–7165.
SUPPLEMENTARY INFORMATION:
Posting of Public Comments
All comments received are considered
part of the public record and made
available for public inspection online at
https://www.regulations.gov and in the
DEA’s public docket. Such information
includes personal identifying
information (such as your name,
address, etc.) voluntarily submitted by
the commenter.
If you want to submit personal
identifying information (such as your
name, address, etc.) as part of your
comment, but do not want it to be
posted online or made available in the
public docket, you must include the
phrase ‘‘PERSONAL IDENTIFYING
INFORMATION’’ in the first paragraph
of your comment. You must also place
all the personal identifying information
you do not want posted online or made
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
37237
available in the public docket in the first
paragraph of your comment and identify
what information you want redacted.
If you want to submit confidential
business information as part of your
comment, but do not want it to be
posted online or made available in the
public docket, you must include the
phrase ‘‘CONFIDENTIAL BUSINESS
INFORMATION’’ in the first paragraph
of your comment. You must also
prominently identify confidential
business information to be redacted
within the comment. If a comment has
so much confidential business
information that it cannot be effectively
redacted, all or part of that comment
may not be posted online or made
available in the public docket.
Personal identifying information and
confidential business information
identified and located as set forth above
will be redacted, and the comment, in
redacted form, will be posted online and
placed in the DEA’s public docket file.
Please note that the Freedom of
Information Act applies to all comments
received. If you wish to inspect the
agency’s public docket file in person by
appointment, please see the FOR
FURTHER INFORMATION CONTACT
paragraph.
Background
Section 306 of the CSA (21 U.S.C.
826) requires the Attorney General to
establish aggregate production quotas
for each basic class of controlled
substance listed in schedules I and II
and for ephedrine, pseudoephedrine,
and phenylpropanolamine. This
responsibility has been delegated to the
Administrator of the DEA through 28
CFR 0.100. The Administrator, in turn,
has redelegated this function to the
Deputy Administrator, pursuant to 28
CFR 0.104. DEA published the 2013
established aggregate production quotas
for controlled substances in schedules I
and II and assessment of annual needs
for the list I chemicals ephedrine,
pseudoephedrine, and
phenylpropanolamine in the Federal
Register (77 FR 59980) on October 1,
2012. That notice stipulated that, as
provided for in 21 CFR 1303.13 and 21
CFR 1315.13, all aggregate production
quotas and assessments of annual need
are subject to adjustment.
Analysis for Proposed Aggregate
Production Quotas for Temporarily
Scheduled Substances
On May 16, 2013, the Deputy
Administrator issued a final order to
temporarily schedule three synthetic
cannabinoids in schedule I of the CSA:
(1-Pentyl-1H-indol-3-yl)(2,2,3,3tetramethylcyclopropyl)methanone
E:\FR\FM\20JNN1.SGM
20JNN1
]]>Agencies
[Federal Register Volume 78, Number 119 (Thursday, June 20, 2013)]
[Notices]
[Page 37237]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-14807]
[[Page 37237]]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[USITC SE-13-015]
Sunshine Act Meeting Notice
AGENCY HOLDING THE MEETING: United States International Trade
Commission.
TIME AND DATE: June 28, 2013 at 11:00 a.m.
PLACE: Room 101, 500 E Street SW., Washington, DC 20436, Telephone:
(202) 205-2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: None.
2. Minutes.
3. Ratification List.
4. Vote in Inv. Nos. 731-TA-1210-1212 (Preliminary) (Welded Stainless
Steel Pressure Pipe from Malaysia, Thailand, and Vietnam). The
Commission is currently scheduled to transmit its determinations to the
Secretary of Commerce on or before July 1, 2013; Commissioners'
opinions are currently scheduled to be transmitted to the Secretary of
Commerce on or before July 9, 2013.
5. Outstanding action jackets: None.
In accordance with Commission policy, subject matter listed above,
not disposed of at the scheduled meeting, may be carried over to the
agenda of the following meeting.
Issued: June 18, 2013.
By order of the Commission.
William R. Bishop,
Supervisory Hearings and Information Officer.
[FR Doc. 2013-14807 Filed 6-18-13; 11:15 am]
BILLING CODE 7020-02-P
